HEALTHCARE
Global Veterinary Therapeutics Market - Industry Trends and Forecast to 2032
REPORT OVERVIEW
Global Veterinary Therapeutics Market, By Type (Anti-Infectives, Anti-Inflammatory, Parasiticides, Analgesics, Sedatives, Others), Product Type (Drugs, Vaccines, Medicated Feed Additives), Animal Type (Companion Animal, Livestock Animal), Route of Administration (Oral, Parenteral, Topical), Distribution Channels (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, Others), Application (Pets, Cattle, Poultry, Swine, Others), Drug stores (Veterinary clinics, Veterinary hospitals, Pharmacies), Region (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2032.
Market Insights
Market Dynamics
- Growing pet ownership and spending on animal health.
- Increasing awareness about animal health.
- High cost of veterinary medicines.
- Stringent regulations for drug approval.
- Expansion in emerging markets.
- Development of novel therapeutics.
- Resistance to antimicrobial agents.
- Lack of skilled veterinarians.
SEGMENTATION
- Type
- Anti-Infectives
- Anti-Inflammatory
- Parasiticides
- Analgesics
- Sedatives
- Others
- Product Type
- Drugs
- Vaccines
- Medicated Feed Additives
- Animal Type
- Companion Animal
- Livestock Animal
- Route of Administration
- Oral
- Parenteral
- Topical
- Distribution Channels
- Veterinary Hospitals
- Veterinary Clinics
- Pharmacies & Drug Stores
- Others
- Application
- Pets
- Cattle
- Poultry
- Swine
- Others
- End-user
- Drug stores
- Veterinary clinics
- Veterinary hospitals
- Pharmacies
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- The Netherlands
- Belgium
- Turkey
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Singapore
- Malaysia
- Australia
- Thailand
- Philippines
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Chile
- Colombia
- Rest of South America
- Middle East and Africa
- Kingdom of Saudi Arabia
- South Africa
- U.A.E.
- Egypt
- Rest of Middle East and Africa
KEY MARKET PLAYERS
- Zoetis
- Intervet Inc. (Merck Animal Health)
- Elanco
- Merial
- Bayer AG
- Boehringer Ingelheim International GmbH
- Ceva
- Vetoquinol S.A.
- IDEXX Laboratories, Inc.
- Virbac
Table OF CONTENTS
- SECTION 1 - INTRODUCTION
- 1.1 Taxonomy
- 1.2 Market Overview
- 1.3 Currency and Limitations
- 1.3.1 Currency
- 1.3.2 Limitations
- 1.4 Key Competitors
- SECTION 2 - RESEARCH METHODOLOGY
- 2.1 Research Approach
- 2.2 Data Collection and Validation
- 2.2.1 Secondary Research
- 2.2.2 Primary Research
- 2.3 Market Assessment
- 2.3.1 Market Size Estimation
- 2.3.2 Bottom-up Approach
- 2.3.3 Top-down Approach
- 2.3.4 Growth Forecast
- 2.4 Market Study Assumptions
- 2.5 Data Sources
- SECTION 3 - EXECUTIVE SUMMARY
- 3.1 Global Veterinary Therapeutics Market, by Type
- 3.2 Global Veterinary Therapeutics Market, by Product Type
- 3.3 Global Veterinary Therapeutics Market, by Animal Type
- 3.4 Global Veterinary Therapeutics Market, by Route of Administration
- 3.5 Global Veterinary Therapeutics Market, by Distribution Channels
- 3.6 Global Veterinary Therapeutics Market, by Application
- 3.7 Global Veterinary Therapeutics Market, by Drug stores
- 3.8 Global Veterinary Therapeutics Market, by Geography
- 3.9 Market Position Grid
- SECTION 4 - PREMIUM INSIGHTS
- 4.1 Regulatory Framework
- 4.1.1 Standards
- 4.1.2 Regulatory Landscape
- 4.2 Value Chain Analysis
- 4.3 Supply Chain Analysis
- 4.4 COVID-19 Impact
- 4.5 Russia-Ukraine War Impact
- 4.6 PORTER's Five Force Analysis
- 4.7 PESTLE Analysis
- 4.8 SWOT Analysis
- 4.9 Go to Market Strategy
- 4.10 Opportunity Orbit
- 4.11 Multivariate Modelling
- 4.12 Pricing Analysis
- SECTION 5 - MARKET DYNAMICS
- 5.1 Trends
- 5.1.1 Increasing adoption of companion animals.
- 5.1.2 Technological advancements in veterinary therapeutics.
- 5.1.3 Trend 3
- 5.2 Drivers
- 5.2.1 Growing pet ownership and spending on animal health.
- 5.2.2 Increasing awareness about animal health.
- 5.2.3 Driver 3
- 5.2.4 Driver 4
- 5.3 Restraints
- 5.3.1 High cost of veterinary medicines.
- 5.3.2 Stringent regulations for drug approval.
- 5.3.3 Restraint 3
- 5.4 Opportunities
- 5.4.1 Expansion in emerging markets.
- 5.4.2 Development of novel therapeutics.
- 5.4.3 Opportunity 3
- 5.4.4 Opportunity 4
- 5.5 Challenges
- 5.5.1 Resistance to antimicrobial agents.
- 5.5.2 Lack of skilled veterinarians.
- 5.5.3 Challenge 3
- SECTION 6 - GLOBAL VETERINARY THERAPEUTICS MARKET, BY TYPE
- 6.1 Type Summary
- 6.2 Market Attractive Index
- 6.3 Global Veterinary Therapeutics Market, by Type (2019-2032)
- SECTION 7 - GLOBAL VETERINARY THERAPEUTICS MARKET, BY PRODUCT TYPE
- 7.1 Product Type Summary
- 7.2 Market Attractive Index
- 7.3 Global Veterinary Therapeutics Market, by Product Type (2019-2032)
- SECTION 8 - GLOBAL VETERINARY THERAPEUTICS MARKET, BY ANIMAL TYPE
- 8.1 Animal Type Summary
- 8.2 Market Attractive Index
- 8.3 Global Veterinary Therapeutics Market, by Animal Type (2019-2032)
- SECTION 9 - GLOBAL VETERINARY THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION
- 9.1 Route of Administration Summary
- 9.2 Market Attractive Index
- 9.3 Global Veterinary Therapeutics Market, by Route of Administration (2019-2032)
- SECTION 10 - GLOBAL VETERINARY THERAPEUTICS MARKET, BY DISTRIBUTION CHANNELS
- 10.1 Distribution Channels Summary
- 10.2 Market Attractive Index
- 10.3 Global Veterinary Therapeutics Market, by Distribution Channels (2019-2032)
- SECTION 11 - GLOBAL VETERINARY THERAPEUTICS MARKET, BY APPLICATION
- 11.1 Application Summary
- 11.2 Market Attractive Index
- 11.3 Global Veterinary Therapeutics Market, by Application (2019-2032)
- SECTION 12 - GLOBAL VETERINARY THERAPEUTICS MARKET, BY DRUG STORES
- 12.1 Drug stores Summary
- 12.2 Market Attractive Index
- 12.3 Global Veterinary Therapeutics Market, by Drug stores (2019-2032)
- SECTION 13 - GLOBAL VETERINARY THERAPEUTICS MARKET, BY GEOGRAPHY
- 13.1 Regional Summary
- 13.2 Market Attractive Index
- 13.3 Global Veterinary Therapeutics Market, by Geography (2019-2032)
- SECTION 14 - NORTH AMERICA VETERINARY THERAPEUTICS MARKET
- 14.1 North America Summary
- 14.2 Market Attractive Index
- 14.3 North America Veterinary Therapeutics Market, by Type (2019-2032)
- 14.4 North America Veterinary Therapeutics Market, by Product Type (2019-2032)
- 14.5 North America Veterinary Therapeutics Market, by Animal Type (2019-2032)
- 14.6 North America Veterinary Therapeutics Market, by Route of Administration (2019-2032)
- 14.7 North America Veterinary Therapeutics Market, by Distribution Channels (2019-2032)
- 14.8 North America Veterinary Therapeutics Market, by Application (2019-2032)
- 14.9 North America Veterinary Therapeutics Market, by Drug stores (2019-2032)
- 14.10 North America Veterinary Therapeutics Market, by Country (2019-2032)
- 14.10.1 U.S.
- 14.10.2 Canada
- 14.10.3 Mexico
- 14.10.4 Rest of North America
- SECTION 15 - EUROPE VETERINARY THERAPEUTICS MARKET
- 15.1 Europe Summary
- 15.2 Market Attractive Index
- 15.3 Europe Veterinary Therapeutics Market, by Type (2019-2032)
- 15.4 Europe Veterinary Therapeutics Market, by Product Type (2019-2032)
- 15.5 Europe Veterinary Therapeutics Market, by Animal Type (2019-2032)
- 15.6 Europe Veterinary Therapeutics Market, by Route of Administration (2019-2032)
- 15.7 Europe Veterinary Therapeutics Market, by Distribution Channels (2019-2032)
- 15.8 Europe Veterinary Therapeutics Market, by Application (2019-2032)
- 15.9 Europe Veterinary Therapeutics Market, by Drug stores (2019-2032)
- 15.10 Europe Veterinary Therapeutics Market, by Country (2019-2032)
- 15.10.1 Germany
- 15.10.2 U.K.
- 15.10.3 France
- 15.10.4 Italy
- 15.10.5 Spain
- 15.10.6 Russia
- 15.10.7 The Netherlands
- 15.10.8 Belgium
- 15.10.9 Turkey
- 15.10.10 Rest of Europe
- SECTION 16 - ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET
- 16.1 Asia-Pacific Summary
- 16.2 Market Attractive Index
- 16.3 Asia-Pacific Veterinary Therapeutics Market, by Type (2019-2032)
- 16.4 Asia-Pacific Veterinary Therapeutics Market, by Product Type (2019-2032)
- 16.5 Asia-Pacific Veterinary Therapeutics Market, by Animal Type (2019-2032)
- 16.6 Asia-Pacific Veterinary Therapeutics Market, by Route of Administration (2019-2032)
- 16.7 Asia-Pacific Veterinary Therapeutics Market, by Distribution Channels (2019-2032)
- 16.8 Asia-Pacific Veterinary Therapeutics Market, by Application (2019-2032)
- 16.9 Asia-Pacific Veterinary Therapeutics Market, by Drug stores (2019-2032)
- 16.10 Asia-Pacific Veterinary Therapeutics Market, by Country (2019-2032)
- 16.10.1 China
- 16.10.2 India
- 16.10.3 Japan
- 16.10.4 South Korea
- 16.10.5 Singapore
- 16.10.6 Malaysia
- 16.10.7 Australia
- 16.10.8 Thailand
- 16.10.9 Philippines
- 16.10.10 Rest of Asia-Pacific
- SECTION 17 - SOUTH AMERICA VETERINARY THERAPEUTICS MARKET
- 17.1 South America Summary
- 17.2 Market Attractive Index
- 17.3 South America Veterinary Therapeutics Market, by Type (2019-2032)
- 17.4 South America Veterinary Therapeutics Market, by Product Type (2019-2032)
- 17.5 South America Veterinary Therapeutics Market, by Animal Type (2019-2032)
- 17.6 South America Veterinary Therapeutics Market, by Route of Administration (2019-2032)
- 17.7 South America Veterinary Therapeutics Market, by Distribution Channels (2019-2032)
- 17.8 South America Veterinary Therapeutics Market, by Application (2019-2032)
- 17.9 South America Veterinary Therapeutics Market, by Drug stores (2019-2032)
- 17.10 South America Veterinary Therapeutics Market, by Country (2019-2032)
- 17.10.1 Brazil
- 17.10.2 Argentina
- 17.10.3 Chile
- 17.10.4 Colombia
- 17.10.5 Rest of South America
- SECTION 18 - MIDDLE EAST AND AFRICA VETERINARY THERAPEUTICS MARKET
- 18.1 Middle East and Africa Summary
- 18.2 Market Attractive Index
- 18.3 Middle East and Africa Veterinary Therapeutics Market, by Type (2019-2032)
- 18.4 Middle East and Africa Veterinary Therapeutics Market, by Product Type (2019-2032)
- 18.5 Middle East and Africa Veterinary Therapeutics Market, by Animal Type (2019-2032)
- 18.6 Middle East and Africa Veterinary Therapeutics Market, by Route of Administration (2019-2032)
- 18.7 Middle East and Africa Veterinary Therapeutics Market, by Distribution Channels (2019-2032)
- 18.8 Middle East and Africa Veterinary Therapeutics Market, by Application (2019-2032)
- 18.9 Middle East and Africa Veterinary Therapeutics Market, by Drug stores (2019-2032)
- 18.10 Middle East and Africa Veterinary Therapeutics Market, by Country (2019-2032)
- 18.10.1 Kingdom of Saudi Arabia
- 18.10.2 South Africa
- 18.10.3 U.A.E.
- 18.10.4 Egypt
- 18.10.5 Rest of Middle East and Africa
- SECTION 19 - COMPANY SHARE ANALYSIS
- 19.1 Global Veterinary Therapeutics Market, Company Share Analysis
- 19.2 North America Veterinary Therapeutics Market, Company Share Analysis
- 19.3 Europe Veterinary Therapeutics Market, Company Share Analysis
- 19.4 Asia-Pacific Veterinary Therapeutics Market, Company Share Analysis
- SECTION 20 - COMPANY PROFILES
- 20.1 Zoetis
- 20.1.1 Company Snapshot
- 20.1.2 Financial Overview
- 20.1.3 Product Portfolio
- 20.1.4 Recent Developments
- 20.2 Intervet Inc. (Merck Animal Health)
- 20.2.1 Company Snapshot
- 20.2.2 Financial Overview
- 20.2.3 Product Portfolio
- 20.2.4 Recent Developments
- 20.3 Elanco
- 20.3.1 Company Snapshot
- 20.3.2 Financial Overview
- 20.3.3 Product Portfolio
- 20.3.4 Recent Developments
- 20.4 Merial
- 20.4.1 Company Snapshot
- 20.4.2 Financial Overview
- 20.4.3 Product Portfolio
- 20.4.4 Recent Developments
- 20.5 Bayer AG
- 20.5.1 Company Snapshot
- 20.5.2 Financial Overview
- 20.5.3 Product Portfolio
- 20.5.4 Recent Developments
- 20.6 Boehringer Ingelheim International GmbH
- 20.6.1 Company Snapshot
- 20.6.2 Financial Overview
- 20.6.3 Product Portfolio
- 20.6.4 Recent Developments
- 20.7 Ceva
- 20.7.1 Company Snapshot
- 20.7.2 Financial Overview
- 20.7.3 Product Portfolio
- 20.7.4 Recent Developments
- 20.8 Vetoquinol S.A.
- 20.8.1 Company Snapshot
- 20.8.2 Financial Overview
- 20.8.3 Product Portfolio
- 20.8.4 Recent Developments
- 20.9 IDEXX Laboratories, Inc.
- 20.9.1 Company Snapshot
- 20.9.2 Financial Overview
- 20.9.3 Product Portfolio
- 20.9.4 Recent Developments
- 20.10 Virbac
- 20.10.1 Company Snapshot
- 20.10.2 Financial Overview
- 20.10.3 Product Portfolio
- 20.10.4 Recent Developments
- SECTION 21 - RELATED REPORTS
- SECTION 22 - DISCLAIMER
RESEARCH METHODOLOGY
RESEARCH AND DATA COLLECTION
- Research articles published on Technium
- Science and MDPI
- Research publications by government approved associations and societies
DATA PRE-PROCESSING
The term "data pre-processing" refers to the collection of procedures and methods used to clean, modify, and make ready for analysis the raw data gathered during research and data collection. The completion of this phase is necessary to guarantee that the data are reliable, consistent, and appropriate for statistical analysis and other data-driven tasks. The data pre-processing ensures that the information gathered from research and data collection is comparable and expressed in standard units, by the integration of missing data pointers and algorithmic approaches.
MODELING AND FORECASTING
QUALITY ASSURANCE AND OUTPUT
Quality assurance and output involves the process of validation, adjustments, further publications of key market indicators. Extensive plausibility and consistency tests are performed on derived time series to ensure the high degree of quality of our market analysis. This quality assurance procedure also includes rigorous inspection, validation, and editing by an experienced management team to assure the dependability of the published data.